Duration to Access Treatment for Psychotic Symptoms
Most people with psychotic symptoms experience a mean delay of approximately 1-2 years (52 weeks to 2 years) before receiving appropriate treatment, though this varies widely from a few weeks to several years. 1, 2
Evidence on Treatment Delays
The duration of untreated psychosis (DUP)—defined as the time between onset of psychotic symptoms and initiation of appropriate treatment—has been extensively studied with consistent findings:
- Mean DUP ranges from 52 weeks to 2 years across multiple studies 1, 2
- The median DUP in one cohort was 57 weeks (approximately 13 months) 3
- Schizophrenia patients experience significantly longer delays (mean 179 days, median 52 days) compared to affective psychosis (mean 15 days, median 12 days) 4
- This delay can extend from a few weeks to several years depending on multiple factors 2
Factors Contributing to Delayed Treatment
The prolonged time to treatment access results from:
- Patient and family denial of illness
- Social withdrawal and isolation from support networks
- Diagnostic errors by healthcare providers
- Paranoid attitudes toward mental health systems
- Prominent negative symptoms that reduce help-seeking behavior
- Poor premorbid functioning correlating with longer delays 2
Clinical Significance of Treatment Delay
DUP shorter than 60 days (2 months) is a critical threshold that significantly predicts better outcomes 5. The evidence demonstrates:
- Longer DUP associates with poorer outcomes across multiple domains: symptom severity, remission rates, relapse risk, global functioning, and quality of life 3, 2
- DUP under 9 months is associated with less severe negative symptoms at both short and long-term follow-up 2
- Patients with DUP greater than 1 year show significantly higher positive symptoms at 6-month follow-up, lower functioning scores, and more enduring psychotic symptoms 3
Current Treatment Guidelines
The most recent 2025 INTEGRATE guidelines emphasize early intervention 6:
- Antipsychotic treatment should be offered after 1 week or more of psychotic symptoms with associated distress or functional impairment
- Even earlier initiation is appropriate when symptoms cause severe distress or pose safety concerns to self or others
- Treatment delays should only be considered when symptoms are clearly substance-related or due to medical conditions without safety concerns
Common Pitfall
The 2005 guidelines noted that patients typically must cross a high threshold of disturbance and risk to gain access to treatment, often having to demonstrate persistent disability to "earn" treatment 7. This reactive approach contradicts evidence showing that early intervention (within 2 months) significantly improves prognosis and reduces vulnerability to recurrent episodes 5.
The critical message: Treatment systems should facilitate access within weeks, not months or years, as the current 1-2 year average delay directly compromises long-term outcomes including symptom burden, functional recovery, and quality of life.